- Report
- May 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- May 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- January 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- July 2024
- 100 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- July 2024
- 100 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- April 2023
- 113 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- June 2025
- 400 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- November 2023
- 120 Pages
North America
From €3099EUR$3,450USD£2,647GBP
- Report
- July 2023
- 80 Pages
United Kingdom
From €1347EUR$1,500USD£1,151GBP
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2023
- 80 Pages
South Korea
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2023
- 80 Pages
Saudi Arabia
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2023
- 80 Pages
India
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2023
- 80 Pages
France
From €1347EUR$1,500USD£1,151GBP
- Report
- July 2023
- 255 Pages
Global
From €1123EUR$1,250USD£959GBP
€2245EUR$2,500USD£1,918GBP
- Report
- April 2024
- 205 Pages
Global
From €3233EUR$3,600USD£2,762GBP
- Report
- April 2024
- 114 Pages
Europe
From €1347EUR$1,500USD£1,151GBP
- Report
- June 2022
- 300 Pages
Global
From €3233EUR$3,600USD£2,762GBP
- Report
- January 2025
- 102 Pages
Global
From €3500EUR$4,174USD£3,094GBP

The Whole Blood market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic products derived from living organisms. Whole Blood is a type of biopharmaceutical product that is derived from human blood, and is used to treat a variety of medical conditions. Whole Blood is typically collected from healthy donors and processed to remove any potential contaminants. It is then stored and distributed to medical facilities for use in transfusions and other treatments.
Whole Blood is used to treat a variety of medical conditions, including anemia, trauma, and cancer. It is also used to replace lost blood during surgery, and to treat patients with severe blood loss due to trauma or illness. Whole Blood is also used in research and development, as it can provide valuable insights into the human body and its response to various treatments.
Some of the major companies in the Whole Blood market include CSL Behring, Grifols, Octapharma, and Kedrion. These companies are involved in the collection, processing, storage, and distribution of Whole Blood products. Show Less Read more